Login / Signup

Rectal ulcer in a hemodialysis patient receiving Kayexalate®.

Julia CollotTayeb SalaouatchiFabienne RickaertAlbino FlorianiBenoit BuysschaertMaria Do Carmo Filomena MesquitaEric Godon
Published in: Clinical case reports (2021)
Kayexalate can cause severe unrecognized GI lesions. Diagnosis of kayexalate crystals in GI biopsy samples is important. Pathologists and clinicians should work hand in hand. New drugs should be available to all patients to treat hyperkalemia.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • case report
  • early onset
  • rectal cancer